Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,065 USD | -1,39% | +17,99% | +33,67% |
Omzet 2024 * | 87,81 mln. 81,81 mln. | Omzet 2025 * | 62,82 mln. 58,53 mln. | Marktkapitalisatie | 276 mln. 257 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -88 mln. -81,99 mln. | Nettowinst (verlies) 2025 * | -130 mln. -121 mln. | EV/omzet 2024 * | 3,14 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,39 x |
K/w-verhouding 2024 * |
-2,95
x | K/w-verhouding 2025 * |
-2,31
x | Werknemers | 449 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 15,06% |
Recentste transcriptie over Adaptimmune Therapeutics plc
1 dag | -1,39% | ||
1 week | +17,99% | ||
Lopende maand | -32,91% | ||
1 maand | -26,39% | ||
3 maanden | +43,83% | ||
6 maanden | +78,24% | ||
Lopend jaar | +33,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 57 | 01-01-08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01-06-23 |
David Mott
CHM | Chairman | 58 | 01-09-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,06 | -1,85% | 302 611 |
24-04-24 | 1,08 | -5,26% | 786 554 |
23-04-24 | 1,14 | +12,87% | 1 133 640 |
22-04-24 | 1,01 | +3,41% | 694 255 |
19-04-24 | 0,9767 | +8,72% | 1 482 450 |
uitgestelde koers Nasdaq, 25 april 2024 om 19:22 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,67% | 276 mln. | |
-2,25% | 104 mld. | |
+1,55% | 97,42 mld. | |
+0,79% | 22,2 mld. | |
-17,80% | 21,23 mld. | |
-11,11% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-16,87% | 15,06 mld. | |
+3,44% | 13,98 mld. | |
+33,90% | 11,66 mld. |